Comparison

Combretastatin A-1 European Partner

Item no. TMO-T36848-50mg
Manufacturer TargetMol
CASRN 109971-63-3
Amount 50 mg
Quantity options 100 mg 1 mL x 10 mM (in DMSO) 10 mg 1 mg 25 mg 50 mg 5 mg
Category
Type Inhibitors
Specific against other
Purity 0,98
Smiles COc1ccc(\C=C/c2cc(OC)c(OC)c(OC)c2)c(O)c1O
ECLASS 10.1 32160490
ECLASS 11.0 32160490
UNSPSC 12000000
Alias Combretastatin A1
Shipping Condition Cool pack
Available
Manufacturer - Targets
Microtubule Associated|||Akt
Shipping Temperature
Cool pack
Storage Conditions
-20
Molecular Weight
332.35
Description
Combretastatin A-1 is a potent microtubule inhibitor with anti-tumour and anti-vascular activity, acting through microtubule protein depolymerisation-mediated inactivation of AKT to inhibit the Wnt/β-catenin pathway, and can be used to study hepatocellular carcinoma.
Pathways
Cytoskeletal Signaling|||PI3K/Akt/mTOR signaling

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 50 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close